Oligonucleotide Synthesis Market Overview:
Oligonucleotide synthesis Market was valued at USD 4.95 Billion in 2021 and is anticipated to grow at a CAGR of 9.5% and is expected to reach USD 11.2 Billion by 2030.
Oligonucleotide synthesis refers to the chemical process of synthesizing small, single-stranded DNA or RNA molecules, called oligonucleotides, with specific sequences. These sequences can be designed to target specific genes or regions within a genome. The process typically involves repeated cycles of chemical reactions to build up the desired oligonucleotide sequence, one nucleotide at a time. Oligonucleotides have various applications in the fields of genomics, gene therapy, and diagnostic assays, among others.
Advancements in genetic research have been a major driver for the oligonucleotide synthesis market. Breakthroughs such as the Human Genome Project and precision medicine have increased the demand for oligonucleotides, which are used in genetic research and testing. This has led to growth in the market. Additionally, the growing investment in biotechnology has attracted more companies to the market and increased the demand for oligonucleotides, further fueling the growth of the oligonucleotide synthesis market.
The synthesis of oligonucleotides is subject to strict regulations, which can raise the cost and complexity of the process, limiting market growth. Additionally, technical difficulties during the synthesis process, such as low yields and impurities, can impact the market negatively.
The increasing use of oligonucleotides in these fields is driving the demand for these products and providing new growth opportunities. Furthermore, the development of new and innovative technologies, such as CRISPR-Cas9 and RNA interference, is also creating new opportunities for the market. As more patients seek out personalized treatment options, the demand for oligonucleotides, which are used as probes and primers in genetic testing, is expected to increase. In addition, advancements in biotechnology and genetic research are creating new applications for oligonucleotides, further expanding the market.
The COVID-19 pandemic has had a significant impact on the oligonucleotide synthesis market. The initial disruptions caused by lockdowns and supply chain disruptions led to a slowdown in the market’s growth. However, the increasing demand for COVID-19 testing and the development of vaccines have provided new opportunities for the oligonucleotide synthesis market. However, the ongoing uncertainty and disruptions caused by the pandemic continue to pose challenges for the market, and it is unclear what the long-term impact of COVID-19 will be on the oligonucleotide synthesis market.
Oligonucleotide synthesis Report Coverage:
|Report Attributes||Report Details|
|Market Size in 2030 (USD Billion)||11.2 Billion|
|By Product||Oligonucleotide-based drugs, Synthesized oligonucleotides, Reagents, Equipment|
|By Application||Therapeutic applications, Research applications, Diagnostic applications|
|By End User||Hospitals, Pharmaceutical & biotechnology companies, Diagnostic laboratories, CROs and CMOs, Academic research institutes|
|By Geography||North America, Europe, Asia Pacific, Latin America, Middle East and Africa|
|Key Players||Ionis Pharmaceuticals, Inc., Kaneka Corporation, Merck Kgaa, Sarepta Therapeutics, Inc., Thermo Fisher Scientific, Inc., Alnylam Pharmaceuticals, Inc., Biogen Limited, Cinven, Danaher Corporation, Eurofins Scientific|
The pharmaceutical industry is growing with the rise of oligonucleotide-based drugs, which use RNA/DNA to target disease genes/pathways, offering advantages over traditional small molecule drugs. Synthesized oligonucleotides, short single-stranded DNA/RNA molecules, have crucial applications in genetic testing, research and drug development. Made through chemical synthesis, the quality of synthesized oligonucleotides (accuracy and purity) determines their suitability for use in PCR, sequencing, and hybridization. The quality of reagents and equipment used in the synthesis process impacts the final product’s accuracy, purity, and yield. Reagents include chemicals, enzymes, and materials, while high-quality equipment is in growing demand with the increase of oligonucleotide use in genetic testing and drug development.
The oligonucleotide synthesis market is segmented into three main applications: therapeutic, research, and diagnostic. Therapeutic applications of oligonucleotides include the use of antisense oligonucleotides, RNA interference, and aptamers for the treatment of various diseases such as cancer, genetic disorders, and cardiovascular diseases. Research applications of oligonucleotides include their use in gene expression analysis, genotyping, and epigenetic studies. Diagnostic applications of oligonucleotides include their use in disease diagnosis, pathogen detection, and personalized medicine.
North America is a significant market for consumer goods and technology products, characterized by high disposable income and well-developed infrastructure. The region is also experiencing growth in its e-commerce sector, fueled by favorable government policies and regulations. These factors contribute to the overall growth of the market in North America. Asia Pacific is a favorable destination for businesses due to its low labor costs and supportive government policies. The region is experiencing growth, driven by the rising middle-class populations and rapid urbanization, which are leading to an increased demand for consumer goods and technology products. These factors are contributing to the overall development and growth of the market in Asia Pacific.
The competitive landscape of the oligonucleotide synthesis market has been evaluated in the report, including the in-depth profiles of leading players in the industry. The growth of the market is driven by the increase in R&D activities, product advancements, diverse business tactics, and the launch of new applications. Some of the key players in the market include-
- Ionis Pharmaceuticals Inc.
- Kaneka Corporation
- Merck Kgaa
- Sarepta Therapeutics Inc.
- Thermo Fisher Scientific Inc.
- Alnylam Pharmaceuticals Inc.
- Biogen Limited
- Danaher Corporation
- Eurofins Scientific
- In January 2023, Thermo Fisher Scientific, a leading provider of scientific instruments and reagents, announced the acquisition of QIAGEN N.V., a global provider of sample and assay technologies, to expand its offerings in the oligonucleotide synthesis market.
- In December 2022, Merck KGaA, a leading provider of life science solutions, announced the launch of a new line of oligonucleotide synthesis products, aimed at improving the efficiency and accuracy of the synthesis process. The new products are expected to increase the company’s market share in the oligonucleotide synthesis market.
Table of Content
To check our Table of Contents, please mail us at: [email protected]
Research MethodologyThe Market Research Community offers numerous solutions and its full addition in the research methods to be skilled at each step. We use wide-ranging resources to produce the best outcome for our customers. The achievement of a research development is completely reliant on the research methods implemented by the company. We always faithful to our clients to find opportunities by examining the global market and offering economic insights.
Market Research Community are proud of our widespread coverage that encompasses the understanding of numerous major industry domains. Company offers consistency in our research report, we also offers on the part of the analysis of forecast across a range of coverage geographies and coverage. The research teams carry out primary and secondary research to carry out and design the data collection methods.